thiazoles has been researched along with Lymphoma, Large B-Cell, Diffuse in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ding, W; Jiang, L; Liu, A; Liu, J; Shi, X; Wen, C; Zhang, H; Zhou, H | 1 |
| Deng, Y; Fan, Z; Guo, X; Huang, C; Ma, R; Meng, M; Wang, F; Yang, D; Zhang, N; Zhao, B | 1 |
| Barrientos, JC; Chadburn, A; Knowles, DM; Lee, FY; Leonard, JP; Lu, P; Wang, YL; Yang, C; Ye, F; Zhang, D | 1 |
| Aloyz, R; Baker, K; Dirnhofer, S; Foulkes, W; Grygorczyk, C; Grygorczyk, R; Hollmann, CA; Martínez-Marignac, VL; Nadeau, J; Tzankov, A | 1 |
| Akao, Y; Horiike, S; Kobayashi, S; Kobayashi, T; Kuroda, J; Matsumoto, Y; Nagoshi, H; Nishida, K; Sasaki, N; Shimura, Y; Taki, T; Taniwaki, M; Tsutsumi, Y; Yamamoto, M | 1 |
| Ansorge, S; Bank, U; Bühling, F; Faust, J; Kähne, T; Kunt, D; Neubert, K; Reinhold, D | 1 |
| Huijgens, PC; Jonkhoff, AR; Martens, HJ; Ossenkoppele, GJ; Teule, GJ; van Dieren, EB; Versteegh, RT | 1 |
| Johnson, TA; Press, OW | 1 |
| Beelen, RH; Broekhoven, MG; Langenhuijsen, MM; Ossenkoppele, GJ; van de Loosdrecht, AA | 1 |
| Beelen, RH; Langenhuijsen, MM; Nennie, E; Ossenkoppele, GJ; van de Loosdrecht, AA | 1 |
10 other study(ies) available for thiazoles and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells.
Topics: Animals; Apoptosis; Cyclin-Dependent Kinases; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Nude; Neoplasm Recurrence, Local; Oxazoles; Thiazoles | 2022 |
Discovery and structure-activity relationship of novel diphenylthiazole derivatives as BTK inhibitor with potent activity against B cell lymphoma cell lines.
Topics: Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Cell Proliferation; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Lymphoma, Large B-Cell, Diffuse; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured | 2019 |
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dasatinib; Drug Resistance, Neoplasm; Humans; Interphase; Intracellular Signaling Peptides and Proteins; Lymphoma, Large B-Cell, Diffuse; Phospholipase C gamma; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptors, Antigen, B-Cell; src-Family Kinases; Syk Kinase; Thiazoles | 2008 |
Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma.
Topics: Antineoplastic Agents; Benzamides; Blotting, Western; Calcium Signaling; Cell Line, Tumor; Cell Separation; Dasatinib; Drug Resistance, Neoplasm; Enzyme Activation; Flow Cytometry; Humans; Imatinib Mesylate; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Microscopy, Fluorescence; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; src-Family Kinases; Thiazoles; Tissue Array Analysis | 2010 |
Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression.
Topics: Aniline Compounds; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Survival; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; Spectral Karyotyping; Sulfonamides; Thiazoles; Translocation, Genetic | 2011 |
Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells.
Topics: Blotting, Western; Cell Division; Cytokines; Dipeptidyl Peptidase 4; DNA; DNA Replication; Humans; Isoelectric Focusing; Lymphoma, Large B-Cell, Diffuse; Lysine; Piperidines; Thiazoles; Tumor Cells, Cultured | 1994 |
Gallium-67 radiotoxicity in human U937 lymphoma cells.
Topics: Cell Division; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplastic Stem Cells; Radiotherapy Dosage; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Yttrium Radioisotopes | 1993 |
Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas.
Topics: Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Agents; Burkitt Lymphoma; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Iodine Radioisotopes; Lymphoma, Large B-Cell, Diffuse; Radioimmunotherapy; Tetrazolium Salts; Thiazoles; Trypan Blue; Tumor Cells, Cultured | 2000 |
Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line.
Topics: Cell Death; Colorimetry; Cytotoxicity, Immunologic; Humans; Immunotherapy, Adoptive; Interferon-gamma; Lymphoma, Large B-Cell, Diffuse; Macrophages; Monocytes; Recombinant Proteins; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study.
Topics: Cell Count; Cells, Cultured; Colorimetry; Coloring Agents; Cytotoxicity Tests, Immunologic; Humans; Lymphoma, Large B-Cell, Diffuse; Macrophages; Monocytes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1991 |